Yulan L. Zhou
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
CD30 CAR-T cells in combination with anti-PD-1 camrelizumab in relapsed/refractory CD30+ lymphomas.
Journal: Journal of translational medicine
Published: December 06, 2025
Clinical characteristics and survival outcomes of patients with immunoglobulin A multiple myeloma in the bortezomib era: A single-center retrospective cohort study
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 14, 2025
Promising Targeted Therapies for Hemophagocytic Lymphohistiocytosis: A Translational Perspective Based on Immunopathology.
Journal: Clinical reviews in allergy & immunology
Published: May 29, 2025
Exploring neutrophil extracellular traps: mechanisms of immune regulation and future therapeutic potential.
Journal: Experimental hematology & oncology
Published: March 23, 2025
A Risk Model Based on sCD25 for Early Mortality in Adult Patients with Hemophagocytic Lymphohistiocytosis.
Journal: International journal of general medicine
Published: January 22, 2025
Application of biomarkers in predicting cardiotoxicity induced by antitumor therapy
Journal: Zhonghua xin xue guan bing za zhi
Published: January 14, 2025
Tryptanthrin impairs platelet function and thrombus formation by reducing Gp1bα expression.
Journal: European journal of pharmacology
Published: August 12, 2024
Identifying the prognostic significance of mitophagy-associated genes in multiple myeloma: a novel risk model construction.
Journal: Clinical and experimental medicine
Published: June 29, 2024
Porcine Anti-Lymphocyte Globulin, Cyclosporine A Plus Thrombopoietin Receptor Agonists Achieved Similar Efficacy and Survival Compared to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Aplastic Anemia.
Journal: International journal of general medicine
Published: May 17, 2024
Last Updated: 09/26/2026